Coronavirus variants: why being more transmissible rather than more deadly isn’t good news
At the heart of this assertion lies an old foe that has plagued us right from the start of this pandemic: exponential growth
Current monkeypox symptoms are different from previous outbreaks, finds study
Rectal pain, penile swelling new complaints; Only a quarter of patients had known contact with a confirmed case
Single nanoparticle twists pave the way for medicines on demand: Study
Understanding chirality — twists within nanoparticles — can help several industries, including pharma
Health ministry confirms 2 more coronavirus variants in India
Uptick in cases in 5 states cannot be linked to these variants as of now, said NITI Aayog member VK Paul
G7 sets renewables target, no timeline for fossil fuel phase out
Gas investments and nuclear energy remain in play while urgent action is needed to phase out fossil fuels
What does Boris Johnson’s plan to ban fuel-powered vehicles mean for UK
Several other countries may follow suit in the coming years to phase out petrol- and diesel-run vehicles
Coronavirus update: Bengal home secy claims community transmission in areas
The UK’s vaccine candidate and a Chinese one, both showed promising results according to research published in The Lancet
US, Japan & others to fund Indonesia’s transition to clean energy
Just Energy Transition Partnership’s $20 bn finance can help freeze the country’s per capita emissions at 2.4 tonnes by 2030
WMO: Hottest year ever in next three, 1.5 degrees Celsius to be breached
This could mean unprecedented heatwaves and other climate impacts all around the world
Human cell ‘membrane on a chip’ can fast track COVID-19 drug testing
The research aims to know how SARS-CoV-2 virus attacks human cell membranes and how it can be blocked
COVID-19: Italy had 5.8 million cases by March 28, says study
Lockdowns reduced transmissibility in European nations but not template for all countries
COVID-19: Phase 3 of vaccine developed by Chinese researchers underway, says Lancet
The Ad5-vectored COVID-19 vaccine tested on people above 55 years of age, is considered a step up from another vaccine being developed by the UK